-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Keros Therapeutics, Inc. quarterly Revenues history and growth rate from Q1 2024 to Q2 2025.
- Keros Therapeutics, Inc. Revenues for the quarter ending June 30, 2025 was $18.2M.